Bill Text: TX HB3026 | 2023-2024 | 88th Legislature | Engrossed


Bill Title: Relating to the administration of a prescription drug manufacturer or third-party prescription assistance program.

Spectrum: Slight Partisan Bill (Democrat 2-1)

Status: (Engrossed - Dead) 2023-05-10 - Referred to Health & Human Services [HB3026 Detail]

Download: Texas-2023-HB3026-Engrossed.html
 
 
  By: Oliverson, Morales of Maverick H.B. No. 3026
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the administration of a prescription drug manufacturer
  or third-party prescription assistance program.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 65.002(b), Health and Safety Code, is
  amended to read as follows:
         (b)  The purpose of this chapter is to authorize the
  commission to establish a program to provide uninsured individuals
  access to prescription drug benefits using money from the fund to
  pay an amount equal to the value of a prescription drug rebate at
  the point of sale and returning that rebate amount to the fund to
  ensure the amounts credited to the fund equal the amounts paid from
  the fund.
         SECTION 2.  Section 65.051(a), Health and Safety Code, is
  amended to read as follows:
         (a)  The commission may [shall] develop and design a
  prescription drug savings program that partners with a pharmacy
  benefit manager to offer prescription drugs at a discounted rate to
  uninsured individuals.
         SECTION 3.  Section 65.204, Health and Safety Code, is
  amended to read as follows:
         Sec. 65.204.  ANNUAL PROGRAM REPORTS.  Not later than
  December 1 of each year following the first year in which the
  program is established, the commission shall provide a written
  report to the governor, lieutenant governor, speaker of the house
  of representatives, and standing committees of the legislature with
  primary jurisdiction over the program. The report must include:
               (1)  a line-item list of all program administrative
  costs incurred by the commission;
               (2)  the amount of the pharmacy benefit manager and
  third-party administrator fees;
               (3)  the aggregate amounts of rebates anticipated and
  received for the program; and
               (4)  other program expenditures as the commission
  determines appropriate.
         SECTION 4.  Subtitle C, Title 2, Health and Safety Code, is
  amended by adding Chapter 66 to read as follows:
  CHAPTER 66. PRESCRIPTION DRUG ASSISTANCE PROGRAM
  SUBCHAPTER A. GENERAL PROVISIONS
         Sec. 66.001.  DEFINITIONS.  In this chapter:
               (1)  "Prescription drug" has the meaning assigned by
  Section 551.003, Occupations Code.
               (2)  "Program" means the prescription drug assistance
  program established under this chapter.
         Sec. 66.002.  CONSTRUCTION OF CHAPTER; PURPOSE. (a) This
  chapter does not establish an entitlement to assistance in
  obtaining benefits for certain individuals.
         (b)  The purpose of this chapter is to authorize the
  commission to establish a program to provide certain individuals
  access to prescription drug benefits using a prescription drug
  manufacturer or third-party prescription assistance programs.
         (c)  This chapter does not expand the Medicaid program.
         Sec. 66.003.  RULES. The executive commissioner may adopt
  the rules necessary to implement this chapter.
  SUBCHAPTER B. ESTABLISHMENT AND ADMINISTRATION OF PRESCRIPTION
  DRUG ASSISTANCE PROGRAM
         Sec. 66.051.  ESTABLISHMENT OF PROGRAM. (a) The commission
  shall develop and design a prescription drug assistance program to
  increase access to prescription drugs for certain individuals
  through a prescription drug manufacturer or other third-party
  patient assistance program.
         (b)  In developing and implementing the program, the
  commission may not exclude from the program benefits prescription
  drugs used for the elective termination of a pregnancy if the drug
  is prescribed:
               (1)  for a purpose other than the elective termination
  of a pregnancy; or
               (2)  to terminate a pregnancy in accordance with an
  exception under Section 170A.002.
         (c)  The commission shall ensure the program is designed to
  provide the greatest value to program enrollees by considering:
               (1)  the adequacy of prescription drugs available
  through the program;
               (2)  the net costs of the drugs to enrollees;
               (3)  the cost to this state; and
               (4)  other important factors as determined by the
  commission.
         Sec. 66.052.  GENERAL POWERS AND DUTIES OF COMMISSION. (a)
  The commission shall oversee the implementation of the program and
  develop procedures for accepting applications for program
  enrollment.
         (b)  The commission shall list in a central location on the
  commission's Internet website information that directs a patient to
  the appropriate assistance available under the program.
         (c)  To the extent feasible, the commission shall integrate a
  prescription drug manufacturer or third-party patient assistance
  program into the prescription drug assistance program. A
  prescription drug manufacturer or other third party may decline to
  link the prescription drug manufacturer's or third party's patient
  assistance program to the prescription drug assistance program.
         Sec. 66.053.  CONTRACT AND GRANT AUTHORITY. (a) The
  commission may contract with a third-party administrator or other
  entity to perform any or all of the commission's program duties
  under this chapter.
         (b)  A third-party administrator or other entity under a
  contract entered into under Subsection (a) may perform the actions
  the commission would otherwise perform to implement the program.
         (c)  The commission may award grants to or enter into other
  arrangements with a governmental entity or nonprofit organization
  to implement this chapter.
         Sec. 66.054.  COMMUNITY OUTREACH AND EDUCATION CAMPAIGN. The
  commission shall conduct a community outreach and education
  campaign to provide information on the program's availability to
  eligible individuals.
  SUBCHAPTER C. FUNDING; PROGRAM SUSPENSION
         Sec. 66.101.  FUNDING.  (a) The commission may accept and
  use money to implement this chapter, including:
               (1)  gifts, grants, and donations;
               (2)  legislative appropriations; and
               (3)  federal money available under law.
         (b)  Money accepted under Subsection (a) may be used only to
  administer the prescription drug assistance program and provide
  program services.
         Sec. 66.102.  SUFFICIENT FUNDING REQUIRED. Notwithstanding
  any other provision of this chapter, the commission is not required
  to implement the program unless appropriated money is made
  available for the program.
         SUBCHAPTER D. PROGRAM ELIGIBILITY AND ENROLLEE REQUIREMENTS
         Sec. 66.151.  ELIGIBILITY CRITERIA.  (a)  Except as provided
  by Subsection (b), an individual is eligible for benefits under the
  program if the individual meets eligibility criteria as determined
  by a prescription drug manufacturer or other third party's
  prescription assistance program.
         (b)  The commission may identify additional factors the
  program must consider for program eligibility.
  SUBCHAPTER E. OPERATION OF PROGRAM
         Sec. 66.201.  PROGRAM BENEFITS. The commission must approve
  program benefits offered under this chapter.  The commission shall
  ensure the benefits comply with all applicable federal and state
  laws and rules.
         Sec. 66.202.  REPORT. (a) A third-party administrator or
  other entity the commission contracts with under Section 66.053
  shall report to the commission in the form and manner prescribed by
  the commission on the benefits and services provided under the
  program.
         (b)  The commission shall establish a procedure to monitor
  the provision of benefits and services under this chapter.
         Sec. 66.203.  ANNUAL PROGRAM REPORT. Not later than
  December 1 of each year, the commission shall provide a written
  report to the governor, lieutenant governor, speaker of the house
  of representatives, and standing committees of the legislature with
  primary jurisdiction over the program. The report must include:
               (1)  a line-item list of all program administrative
  costs incurred by the commission, including costs incurred by a
  third-party administrator or other entity;
               (2)  the aggregate amount of prescription drug cost
  savings accrued under the program; and
               (3)  other program expenditures as the commission
  determines appropriate.
         SECTION 5.  Section 65.102, Health and Safety Code, is
  repealed.
         SECTION 6.    The Health and Human Services Commission is
  required to implement a provision of this Act only if the
  legislature appropriates money specifically for that purpose. If
  the legislature does not appropriate money specifically for that
  purpose, the Health and Human Services Commission may, but is not
  required to, implement a provision of this Act using other
  appropriations available for that purpose.
         SECTION 7.  As soon as practicable after the effective date
  of this Act, the executive commissioner of the Health and Human
  Services Commission and any other state agency designated by the
  executive commissioner shall adopt rules necessary to implement
  Chapter 65, Health and Safety Code, as amended by this Act, and
  Chapter 66, Health and Safety Code, as added by this Act.
         SECTION 8.  This Act takes effect September 1, 2023.
feedback